01/01/2020 · Get the latest Sonoma Pharmaceuticals, Inc. SNOA stock news and headlines to help you in your trading and investing decisions. Real-time trade and investing ideas on Sonoma Pharmaceuticals, Inc. SNOA from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal.
01/11/2019 · Sonoma Pharmaceuticals, Inc. We originally incorporated as Micromed Laboratories, Inc. in 1999 under the laws of the State of California. We changed our name to Oculus Innovative Sciences, Inc. in 2001. In December 2006 we reincorporated under the laws of the State of Delaware and in December 2016, we changed our name to Sonoma Pharmaceuticals. Sonoma Pharmaceuticals earned a daily sentiment score of -3.3 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Sonoma Pharmaceuticals.
31/12/2019 · Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. The company offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin. Sonoma Pharmaceuticals, Inc. SNOA News – Find the latest company news headlines for Sonoma Pharmaceuticals, Inc. and all the companies you research at.
What is Sonoma Pharmaceuticals, Inc.'s stock symbol? Our stock is traded on the Nasdaq under the symbol SNOA. When was Sonoma Pharmaceuticals, Inc. incorporated? The company was incorporated in California in 1999 as Micromed Laboratories, Inc. In August 2001, the company changed its name to Oculus Innovative Sciences, Inc. Sonoma Pharmaceuticals Announces Closing of $1.6 Million Public Offering of Common Stock Nov 29, 2019 Sonoma Pharmaceuticals Announces Pricing of Approximately $1.6 million Public Offering of Common Stock.
Sonoma Pharmaceuticals has established strategic partnerships around the globe with leaders in the dermatology, advanced tissue care and animal healthcare markets. Europe. Sonoma Pharmaceuticals is partnered with industry-leading distributors in multiple countries throughout Europe. At Sonoma Pharmaceuticals, we love to help to our customers or doctors. Whether it’s finding more information about our products or where to get it, we’ll do our best to help you. 17/06/2019 · Sonoma Pharmaceuticals, Inc. Common Stock SNOA Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. Home; About; Products. Dermatology. Prescription Products. Epicyn Antimicrobial Facial Cleanser; Levicyn Antimicrobial Dermal Spray; Levicyn Antipruritic Gel. Stock analysis for Sonoma Pharmaceuticals Inc SNOA:NASDAQ CM including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Historical daily share price chart and data for Sonoma Pharmaceuticals since 2019 adjusted for splits. The latest closing stock price for Sonoma Pharmaceuticals as of December 11, 2019 is 4.36. The all-time high Sonoma Pharmaceuticals stock closing price was 7.92. SNOAW Complete Sonoma Pharmaceuticals Inc. Wt stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. The company offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, sca. Get breaking news and analysis on Sonoma Pharmaceuticals, Inc. SNOA stock, price quote and chart, trading and investing tools. 26/11/2019 · The shares of common stock were being offered and sold to the public pursuant to the Company's registration statement on Form S-3 and an accompanying prospectus. Sonoma Pharmaceuticals Inc. published this content on 29 November 2019 and is solely responsible for the information contained therein. SNOA Real Time Stock Quote - Get Sonoma Pharmaceuticals, Inc. Common Stock SNOA last sale data in real-time at.
Company profile page for Sonoma Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information. Skip To Content. Skip to content. Bloomberg the Company & Its Products Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Terminal Demo Request. Stock quote for Sonoma Pharmaceuticals, Inc. Common Stock Common Stock SNOA with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. 26/11/2019 · PETALUMA, Calif., Nov. 25, 2019 GLOBE NEWSWIRE -- Sonoma Pharmaceuticals, Inc. Nasdaq: SNOA today announced the launch of a “best efforts” public offering of shares of its common stock. Dawson James Securities, Inc. is acting as the lead placement agent and sole book runner. Sonoma. Sonoma Pharmaceuticals Inc. Wt company facts, information and stock details by MarketWatch. View snoaw business summary and other industry information.
Sonoma Pharmaceuticals operates as a pharmaceutical company. It develops and markets solutions for the treatment of dermatological conditions, animal health and advanced tissue care. The company operates primarily in United States, Latin America and Europe. Sonoma Pharmaceuticals formerly known as Oculus. Sonoma Pharmaceuticals Stock Price, Chart, Latest News, Technical Indicator and other information. Sonoma Pharmaceuticals stock quote and SNOA charts. Latest stock price today and the US's most active stock market forums. Sonoma Pharmaceuticals SNOA stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.
: Get the latest Sonoma Pharmaceuticals stock price and detailed information including news, historical charts and realtime prices. Sonoma Pharmaceuticals NASDAQ:SNOA STOCK IN FOCUS: Overbought and Oversold levels. The stock has RSI reading of 28.92. RSI gives an indication of.
Sonoma Pharmaceuticals NASDAQ:SNOA Price Target and Consensus Rating MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months.
Estádios De Futebol Espanhol
Dor No Punho E Nos Dedos Insensíveis
Murdoch Thomas E Amigos De Madeira
Figuras Do Tio Owen Tia Beru
Raven Teen Titans Desenho
Estilo Fixo De Liderança
Nike Air Force 1 Tamanho 7 Homem
Tony Bianco Botas De Prata
Andrew Nome Significado
Todos Os Álbuns Ikon
Baitcaster Verde Limão
Tratamento Alternativo Para Tireóide Hipoativa
Navegação Nos Mapas Amazfit Bip
This Is Us Episódio 4 Preview
Porsche Carrera 1990
Onde Posso Obter Uma Cópia Da Minha Certidão De Casamento
Funko Pop 195
Penteados Simples Bonitos Do Coque
De Volta À Igreja Domingo 2018
Inchaço Da Panturrilha Direita
Kool Radio 100.1
Empregos De Investigador Sênior
Download Da Atualização 8 Do Java 8
Foxhall Bridge Club
Dr. Paulette Stewart
Limpador De Registros Spin Clean
Nissan Gtr R29
Camisolas De Primavera Para Senhoras
Design De Interiores Minimalista Sueco
Meio Quilo Em Libras
Filmes De Natal Da Hallmark Em 2019
Nas Últimas Citações Selvagens
Aldeias De Morgan Metro Apartments
Lenço De Cabeça Com Tranças
Hoka One One Bondi 6 Amazon
Beneficie O Tamanho Da Viagem Pré-profissional
Câmera Digital Canon Eos Rebel T6 De 18mp
Yale Cisco Anyconnect
Renaldo Balkman Tênis
Mensagens Longas Doces Para Namorada